These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14498848)

  • 1. Effects of dopamine antagonists on alfentanil-induced locomotor activity in horses.
    Pascoe PJ; Taylor PM
    Vet Anaesth Analg; 2003 Jul; 30(3):165-71. PubMed ID: 14498848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H; Gerlach J; Mørkeberg F
    Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic dopamine D1, dopamine D2 and combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys: antiamphetamine effects and extrapyramidal side effects.
    Peacock L; Hansen L; Mørkeberg F; Gerlach J
    Neuropsychopharmacology; 1999 Jan; 20(1):35-43. PubMed ID: 9885783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine.
    Tanabe LM; Suto N; Creekmore E; Steinmiller CL; Vezina P
    Behav Pharmacol; 2004 Sep; 15(5-6):387-95. PubMed ID: 15343065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined scopolamine and ethanol treatment results in a locomotor stimulant response suggestive of synergism that is not blocked by dopamine receptor antagonists.
    Scibelli AC; Phillips TJ
    Alcohol Clin Exp Res; 2009 Mar; 33(3):435-47. PubMed ID: 19120057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP; Rogawski MA
    Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
    Wise RA; Carlezon WA
    Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL; O'Dell LE; Redmond JC
    Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats.
    Garrett BE; Holtzman SG
    Pharmacol Biochem Behav; 1994 Jan; 47(1):89-94. PubMed ID: 7906891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of narcotic analgesics in the horse: selective blockade of narcotic-induced locomotor activity.
    Combie J; Shults T; Nugent EC; Dougherty J; Tobin T
    Am J Vet Res; 1981 May; 42(5):716-21. PubMed ID: 6114692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of dopamine antagonists to inhibit the locomotor effects of cocaine in sensitized and non-sensitized C57BL/6 mice depends on the challenge dose.
    Prinssen EP; Colpaert FC; Kleven MS; Koek W
    Psychopharmacology (Berl); 2004 Apr; 172(4):409-14. PubMed ID: 14668976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine agonists and antagonists on locomotor activity in male and female rats.
    Schindler CW; Carmona GN
    Pharmacol Biochem Behav; 2002 Jul; 72(4):857-63. PubMed ID: 12062575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization.
    Jeziorski M; White FJ
    Eur J Pharmacol; 1995 Mar; 275(3):235-44. PubMed ID: 7768290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice.
    Shen EH; Crabbe JC; Phillips TJ
    Psychopharmacology (Berl); 1995 Mar; 118(1):28-36. PubMed ID: 7597119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor antagonists block nerve growth factor-induced hyperactivity.
    Kobayashi S; Ogren SO; Ebendal T; Olson L
    Eur J Pharmacol; 1997 May; 326(1):1-5. PubMed ID: 9178648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice.
    Chausmer AL; Katz JL
    Psychopharmacology (Berl); 2001 Apr; 155(1):69-77. PubMed ID: 11374338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice.
    Cook CD; Beardsley PM
    Pharmacol Biochem Behav; 2003 May; 75(2):363-71. PubMed ID: 12873628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of methiopropamine-induced locomotor sensitization requires dopamine D2, but not D1, receptor activation in the rat.
    Yoon HS; Cai WT; Lee YH; Park KT; Lee YS; Kim JH
    Behav Brain Res; 2016 Sep; 311():403-407. PubMed ID: 27265782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.